| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 300 shares Citigroup Common | 148,663 | 18,498 |
| 50 shares Gilead Sciences Common | 5,047 | 2,913 |
| 845 shares Gilead Sciences Common | 16,389 | 49,521 |
| Description | Amount |
|---|---|
| rounding | 1 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| investment expenses | 180 | 180 | 180 | 180 |
| none | 0 | 0 | 0 | 0 |
| Category | Gross Sales | Cost of Goods Sold | Net (Gross Sales Minus Cost of Goods Sold) |
|---|---|---|---|
| inventory | 3,199 | 868 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Nys Filing Fee and irs | 103 | 103 | 0 | 103 |